Enzyme-linked Immunosorbent Assay (Elisa) Market- Roadmap for Recovery from COVID-19|Increasing Incidences Of Cancer to Boost the Market Growth | Technavio
Technavio has been monitoring the enzyme-linked immunosorbent assay (Elisa) market and it is poised to grow by USD 124.55 mn during 2020-2024, progressing at a CAGR of about 5% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.
Although the COVID-19 pandemic continues to transform the growth of various industries, the immediate impact of the outbreak is varied. While a few industries will register a drop in demand, numerous others will continue to remain unscathed and show promising growth opportunities. Technavio's in-depth research has all your needs covered as our research reports include all foreseeable market scenarios, including pre- & post-COVID-19 analysis. Download a Free Sample Report on COVID-19 Impacts
Frequently Asked Questions:
What are the major trends in the market?
Rising demand for frequent diagnostic testing for aging population is a major trend driving the growth of the market.
At what rate is the market projected to grow?
The year-over-year growth for 2020 is estimated at 3.99% and the incremental growth of the market is anticipated to be $ 124.55 mn.
Who are the top players in the market?
Abbott Laboratories, Abcam Plc, Avantor Inc., bioMerieux SA, Bio-Rad Laboratories Inc., Danaher Corp., Eppendorf AG, GlaxoSmithKline Plc, Siemens Healthineers AG, and Thermo Fisher Scientific Inc., are some of the major market participants.
What is the key market driver?
The increasing incidences of cancer is one of the major factors driving the market.
How big is the APAC market?
The APAC region will contribute 40% of the market share.
The market is fragmented, and the degree of fragmentation will accelerate during the forecast period. Abbott Laboratories, Abcam Plc, Avantor Inc., bioMerieux SA, Bio-Rad Laboratories Inc., Danaher Corp., Eppendorf AG, GlaxoSmithKline Plc, Siemens Healthineers AG, and Thermo Fisher Scientific Inc. are some of the major market participants. The increasing incidences of cancer will offer immense growth opportunities. To make most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.
Technavio's custom research reports offer detailed insights on the impact of COVID-19 at an industry level, a regional level, and subsequent supply chain operations. This customized report will also help clients keep up with new product launches in direct & indirect COVID-19 related markets, upcoming vaccines and pipeline analysis, and significant developments in vendor operations and government regulations.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. The enzyme-linked immunosorbent assay market report covers the following areas:
Enzyme-linked Immunosorbent Assay Market Size
Enzyme-linked Immunosorbent Assay Market Trends
Enzyme-linked Immunosorbent Assay Market Industry Analysis
This study identifies rising demand for frequent diagnostic testing for the aging population as one of the prime reasons driving the enzyme-linked immunosorbent assay market growth during the next few years.
Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavio's in-depth research has direct and indirect COVID-19 impacted market research reports.
CAGR of the market during the forecast period 2020-2024
Detailed information on factors that will assist enzyme-linked immunosorbent assay market growth during the next five years
Estimation of the enzyme-linked immunosorbent assay market size and its contribution to the parent market
Predictions on upcoming trends and changes in consumer behavior
The growth of the enzyme-linked immunosorbent assay market
Analysis of the market's competitive landscape and detailed information on vendors
Comprehensive details of factors that will challenge the growth of enzyme-linked immunosorbent assay market vendors
Table of Contents:
Executive Summary
Market Overview
Market Landscape
Market ecosystem
Value chain analysis
Market Sizing
Market definition
Market segment analysis
Market size 2019
Market outlook: Forecast for 2019 - 2024
Five Forces Analysis
Five Forces Summary
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition
Market Segmentation by End-user
Market segments
Comparison by End-user placement
Hospitals and diagnostic centers - Market size and forecast 2019-2024
Research laboratories - Market size and forecast 2019-2024
Others - Market size and forecast 2019-2024
Market opportunity by End-user
Customer landscape
Overview
Geographic Landscape
Geographic segmentation
Geographic comparison
North America - Market size and forecast 2019-2024
Europe - Market size and forecast 2019-2024
APAC - Market size and forecast 2019-2024
MEA - Market size and forecast 2019-2024
South America - Market size and forecast 2019-2024
Key leading countries
Market opportunity by geography
Drivers, Challenges, and Trends
Market drivers
Volume driver - Demand led growth
Volume driver - Supply led growth
Volume driver - External factors
Volume driver - Demand shift in adjacent markets
Price driver - Inflation
Price driver - Shift from lower to higher priced units
Market challenges
Market trends
Vendor Landscape
Overview
Vendor landscape
Landscape disruption
Vendor Analysis
Vendors covered
Market positioning of vendors
Abbott Laboratories
Abcam Plc
Avantor Inc.
bioMerieux SA
Bio-Rad Laboratories Inc.
Danaher Corp.
Eppendorf AG
GlaxoSmithKline Plc
Siemens Healthineers AG
Thermo Fisher Scientific Inc.
Appendix
Scope of the report
Currency conversion rates for US$
Research methodology
List of abbreviations
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Anodot publishes its annual Cloud Cost Optimization Report, delivering insights from customer data and analysis of news and trends within the FinOps sector to prepare cloud users for 2024....
Pieris Pharmaceuticals, Inc. today announced that its Board of Directors has approved a 1-for-80 reverse stock split of the Company's common stock, par value $0.001, which will be effective at 5:00 pm Eastern Time on April 22, 2024. The Company's...
Phenom today announced IAMPHENOM ? the human resources event for talent acquisition, talent management, CHROs, HRIS and executives ? has sold out with record-breaking registrations and is reaching maximum capacity. Waitlisting is now available.
The...
Sony Electronics Inc. today announced a new addition to its line of car AV receivers, the XAV-AX3700. The XAV-AX3700 includes a customizable experience to fit user's personal viewing preference, while providing optimal sound. This new model includes...
TransAlta Corporation ("TransAlta" or the "Company") announced today that it has signed onto a voluntary water-sharing memorandum of understanding ("MOU") with over thirty other water licence holders in the Bow River Basin. Water-sharing MOUs have...
Wipro Limited , a leading technology services and consulting company, announced financial results under International Financial Reporting Standards (IFRS) for the quarter and year ended March 31, 2024.
Highlights of the Results
Results for the...